tezosentan has been researched along with ng-nitroarginine methyl ester in 2 studies
Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) | Studies (ng-nitroarginine methyl ester) | Trials (ng-nitroarginine methyl ester) | Recent Studies (post-2010) (ng-nitroarginine methyl ester) |
---|---|---|---|---|---|
157 | 29 | 33 | 12,640 | 117 | 2,342 |
Protein | Taxonomy | tezosentan (IC50) | ng-nitroarginine methyl ester (IC50) |
---|---|---|---|
Neutrophil elastase | Homo sapiens (human) | 2.7 | |
Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.1 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 1.1167 | |
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.6 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 8 | |
Collagenase 3 | Homo sapiens (human) | 2.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böttiger, BW; Motsch, J; Rauch, H | 1 |
Beck, C; Picker, O; Scheeren, TW; Schindler, AW; Schwarte, LA | 1 |
1 review(s) available for tezosentan and ng-nitroarginine methyl ester
Article | Year |
---|---|
Newer approaches to the pharmacological management of heart failure.
Topics: Calcium Signaling; Cardiotonic Agents; Cardiovascular Agents; Endothelins; Enzyme Inhibitors; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridazines; Pyridines; Simendan; Tetrazoles | 2006 |
1 other study(ies) available for tezosentan and ng-nitroarginine methyl ester
Article | Year |
---|---|
Endogenous nitric oxide reduces the efficacy of the endothelin system to maintain blood pressure during high epidural anaesthesia in conscious dogs.
Topics: Anesthesia, Epidural; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Dogs; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Female; Hormone Antagonists; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyridines; Random Allocation; Receptors, Endothelin; Receptors, Vasopressin; Tetrazoles; Vascular Resistance; Vasopressins | 2007 |